DiNuzzo Private Wealth’s Catalyst Pharmaceutical CPRX Stock Holding History

DiNuzzo Private Wealth’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-3	Closed	-$95	–	1373
2026 Q2	$95	Buy	+3	New	+$89	﹤0.01%	1299
2024 Q1	–	Sell	-1	Closed	-$17	–	1375
2023 Q4	$17	Buy	+1	New	+$14	﹤0.01%	1381

Other funds holding CPRX

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

DiNuzzo Private Wealth's CPRX Position: Q3 2026 in Review

DiNuzzo Private Wealth sold out of Catalyst Pharmaceutical (CPRX) in Q3 2026, closing a stake of 3 shares — an estimated $95 sold.

DiNuzzo Private Wealth first reported a position in CPRX in Q4 2023 and held it in 2 quarters. The position peaked at $95 in Q2 2026. 1 fund tracked by Wall St. Rank holds CPRX as of Q3 2026.

DiNuzzo Private Wealth reported no remaining Catalyst Pharmaceutical position as of Q3 2026 after selling out during the quarter.
DiNuzzo Private Wealth sold 3 Catalyst Pharmaceutical shares in Q3 2026, an estimated $95.
DiNuzzo Private Wealth first reported a position in Catalyst Pharmaceutical in Q4 2023 and held it in 2 quarters.
DiNuzzo Private Wealth's Catalyst Pharmaceutical position peaked at $95 in Q2 2026.
1 fund tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q3 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q3 2026, filed 16 Oct 2026.